Mepitel and Mepitel One are cost-effective

 

Besides the obvious savings fewer dressing changes and fewer wasted dressings during application represent, Mepitel dressings also contribute to overall lower wound care costs: less need for costly pain management and
less risk for healing setbacks that can extend the need for ongoing care.

  • Research shows a strong relationship between pain at dressing procedures and higher overall care costs.
  • The psychological and physiological impacts of pain require added staff time and analgesic, pain or anxiety medication costs that contribute significantly to the overall expense of wound care.
  • This financial burden dwarfs the cost of the dressing itself – implying an opportunity to invest in dressings with Safetac as a way to minimise the true costs of treatment.

References

Home >

   
Share this